BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

GenKyoTex S.A.  

16, Chemin des Aulx
CH-1228, Plan-Les-Ouates
  Geneva    Switzerland
Phone: 41-0-22-880-10-25 Fax: 41-0-22-880-10-13


SEARCH JOBS










 Company News
GenKyoTex S.A. 's GKT137831 Found To Reverse Fibrosis And Improve Survival In A Model Of Persistent Lung Fibrosis 4/10/2014 9:22:56 AM    More...
GenKyoTex S.A. NOX Inhibitor GKT137831 Successfully Shown To Halt Diabetic Kidney Disease 11/11/2013 9:06:20 AM    More...
GenKyoTex S.A. Collaborators Elucidate Role of NOX4 in Osteoporosis 10/21/2013 10:03:17 AM    More...
GenKyoTex S.A. Receives FDA IND Approval for Phase II Clinical Study With First in Class NOX Inhibitor GKT137831 9/9/2013 10:22:40 AM    More...
GenKyoTex S.A. 's First in Class NOX Inhibitor GKT137831 to be Presented at Kidney Week 2012 10/15/2012 10:18:39 AM    More...
GenKyoTex S.A. s Lead NOX Inhibitor GKT137831 Demonstrates Activity in Models of Liver Fibrosis 8/8/2012 10:21:51 AM    More...
GenKyoTex S.A. Raises $26 Million for Phase II Development of Diabetic Nephropathy Drug 7/9/2012 7:18:28 AM    More...
GenKyoTex S.A. Announces Successful Phase Ia Data with First in Class NOX Inhibitor GKT137831 6/22/2012 10:14:44 AM    More...
GenKyoTex S.A. Starts Phase I Trial with First in Class NOX Inhibitor GKT137831 11/2/2011 10:28:38 AM    More...